Detección de la hipertensión arterial pulmonar en esclerosis sistémica basada en la evidencia: Estudio DETECT
Detección de la hipertensión arterial pulmonar en esclerosis sistémica basada en la evidencia: Estudio DETECT
Contenido principal del artículo
Descargas
Detalles del artículo
Referencias (VER)
Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis
Rheum. 2005;52:3792–800.
Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum
Dis. 2003;62:1088–93.
Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary
Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J.
;30:2493–537.
Mukerjee D, St George D, Knight C, Davar J, Wells AU, Du Bois RM, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology. 2004;43:461-6.
Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum. 2011;63:3522–30.
Galiè N, Rubin Lj, Hoeper M, Jansa P, Al-Hiti H, Meyer G. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind randomized controlled trial. Lancet. 2008;371:2093–100.